Presentation: – solution for injections 1 mg/ml 1 ml ampoules 5 units per pack
Included in the List of Vital and Essential Drugs
Registration number: LS-001849 By prescription
Pharmacotherapeutic group: - and β-adrenergic agonists.
Indications for use:
♦ immediate-type allergic reactions (including urticaria, angioedema, anaphylactic shock) caused by the use of drugs, serums, blood transfusions, consumption of foods, insect bites or other allergens;
♦ exercise-induced asthma;
♦ bronchial asthma (relief of status asthmaticus), bronchospasm during anesthesia;
♦ asystole (including with the acutely developing III degree atrioventricular block);
♦ bleeding from the superfi cial vessels of the skin and mucous membranes
(including the gums);
♦ arterial hypotension that cannot be reversed by giving adequate replacement fl uids (including shock, bacteremia, open heart surgery, renal failure);
♦ necessity to prolong the effect of local anesthetics;
♦ episodes of complete atrioventricular block (with the development of syncope (Morgagni–Adams–Stokes syndrome));
♦ arrest of bleeding (as a vasoconstrictor).
Shelf life: 3 years.